Jupiter earnings for the second quarter of fiscal 2027 included income of INR 456.5 crore and profit after tax of INR 56.4 crore, as the hospital operator’s Dombivli facility sharply narrowed its operating loss from the preceding quarter.
Key Takeaways
- Dombivli’s EBITDA loss fell to INR 0.2 crore from INR 9.5 crore in the first quarter, although occupancy remained in the mid-30s.
- Net debt was roughly INR 170 crore at the end of the second quarter, with a term loan intended to fund three expansion projects.
- Management does not provide financial guidance and expects some seasonal moderation in third-quarter occupancy.
Jupiter earnings and the Dombivli ramp-up
Jupiter Life Line Hospitals reported EBITDA of INR 106.9 crore for fiscal Q2 2027. EBITDA measures earnings before interest, taxes, depreciation and amortization.
At Dombivli, the EBITDA loss narrowed from INR 9.5 crore in Q1 to INR 0.2 crore in Q2. Chief Executive Ankit Thakkar said it was difficult to separate the benefit of seasonal infectious-disease admissions from underlying growth.
Thakkar said occupancy is traditionally lower in Q3 than in Q2 across the group’s hospitals, so some moderation should be expected. He nevertheless said Dombivli’s broader ramp-up remained intact.
| Item | Details |
|---|---|
| Q2 FY27 income | INR 456.5 crore |
| Q2 FY27 EBITDA | INR 106.9 crore |
| Q2 FY27 profit after tax | INR 56.4 crore |
| End-Q2 net debt | Approximately INR 170 crore |
Insurance access and mature hospital capacity
Dombivli’s occupancy was in the mid-30s, and the hospital remained weighted toward self-paying patients because cashless insurance empanelment was pending. Thakkar said the process typically takes about a year and requires accreditation before insurers can complete empanelment.
Most specialties at Dombivli had started, while transplants had yet to begin. Thakkar expected transplant services to start in the next couple of quarters and radiation oncology, which was being commissioned, to begin in the next quarter.
At the mature hospitals, Thane occupancy was approximately 75% and Pune occupancy close to 70%. Thakkar said Thane could add beds only with regulatory clearance, which had not yet been received; Pune had no further expansion scope but retained room to increase occupancy.
At Indore, EBITDA remained flat despite revenue growth of around 18%. Thakkar attributed the performance to continued investment in medical teams and said profitability and occupancy could fluctuate as beds are added.
Expansion funding and debt
Jupiter acquired land for its Pune South hospital for INR 150 crore, with an incremental cash outflow of INR 100 crore. Thakkar said the company’s INR 500 crore term loan would fund the Pune South, Mira Road and BKC projects, including INR 100 crore toward the Pune South land purchase.
Net debt stood at roughly INR 170 crore at the end of Q2. Thakkar said the board had set a self-imposed debt ceiling of three times EBITDA. At Mira Road, about INR 75 crore to INR 80 crore had been spent, largely on land, with construction spending to follow once regulatory approvals are in place.
Read More News
Disclaimer
This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.
Comments
Be respectful. No spam, impersonation or private credentials. Ordinary posts and comments appear immediately; suspicious links are held for review.
Please wait…